//-- 2. Rosy Scope Study, cost could be revised up significantly; --//
The scoping study was quite conservative - based on contracts at $45/lb. BMN could conceivably get double that on market.
You are correct - costs could increase, anything can happen before mine is operational. That is why market cap is low. If there were no risks involved then BMN would be worth more than PDN and trading over $10. IMO market is currently seriously overstating the risks.
//-- 2. Rosy Scope Study, cost could be revised up...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BMN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.30 |
Change
-0.170(4.90%) |
Mkt cap ! $589.4M | |||
| Open | High | Low | Value | Volume |
| $3.41 | $3.42 | $3.29 | $1.679M | 503.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1784 | $3.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.36 | 8000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BMN (ASX) Chart |